Security key
03835L306
Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO)
CUSIP: 03835L306
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 1,963,743
- Total 13F value
- $599,087
- Share change
- +1,961,100
- SEC-reported price per share
- $0.31
- Number of holders
- 18
- Value change
- +$598,269
- Number of buys
- 11
- Number of sells
- 3
- Shares outstanding
- 2,864,322
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
18
Top holders
10
APVO full security history
Ownership snapshot
Full 13F holder table
Aptevo Therapeutics Inc. SEC filings
Aptevo Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Tower Research Capital LL...
Disclosed value leader
Tower Research Capital LL...
Comparable rows
0/11
Latest evidence
31 Mar 2024
13F
3/4/5
Highest disclosed value: $6,209
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
Tower Research Capital LLC (TRC) has the largest disclosed position value at $6.2K.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Tower Research Capital LLC (TRC)'s linked filing trail.
Disclosed position value
Top 5
Tower Research Capital LLC (TRC)
$6.2K
BlackRock Finance, Inc.
$4.2K
MORGAN STANLEY
$910
Qube Research & Technologies Ltd
$469
OSAIC HOLDINGS, INC.
$211
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) |
13F
Company
|
—
denominator unverified
|
$6,209
1,324 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$4,174
890 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$910
194 shares
|
— | 31 Mar 2024 |
| Qube Research & Technologies Ltd |
13F
Company
|
—
denominator unverified
|
$469
100 shares
|
— | 31 Mar 2024 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
—
denominator unverified
|
$211
45 shares
|
— | 31 Mar 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
denominator unverified
|
$202
43 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
1,963,743
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
10
Q2 2024 holders
18
Holder diff
8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|